LadRx (CYTR) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 94 192 sessions, December 31, 2021 to October 5, 2022
- Largest daily move
- -34.4% close of April 18, 2022
- 5-year change
- -96.3% closing prices, October 5, 2017 to October 5, 2022
Company Description
LadRx (OTC: CYTR) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $4.1M.
CYTR has declined 81.8% so far this year. The last closing price was $0.0920.
This page collects what Stock Titan holds for CYTR, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
LadRx (CYTR) closed at $0.0920 on October 5, 2022. So far this year, the price has lost 81.8%.
CYTR Metrics & Rankings
Price returns through October 5, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
LadRx has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include management, partnership. View all CYTR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CYTR Company Profile & Sector Positioning
LadRx (CYTR) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing CYTR often look at related companies in the same sector, including Azitra Inc (AZTR), CNS Pharmaceuticals, Inc. (CNSP), Claritas Pharmaceuticals Inc (KALTF), XORTX Therapeutics Inc. (XRTX), and Theriva Biologics, Inc. (TOVX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CYTR's relative position within its industry.